US 8507445
Compositions and methods of use of targeting peptides for diagnosis and therapy of human cancer
granted A61KA61K38/00A61K45/06
Quick answer
US patent 8507445 (Compositions and methods of use of targeting peptides for diagnosis and therapy of human cancer) held by The Board of Regents of the University of Texas System expires Mon Aug 08 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Board of Regents of the University of Texas System
- Grant date
- Tue Aug 13 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 08 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 23
- CPC classes
- A61K, A61K38/00, A61K45/06, A61K47/64, A61K47/642